Point72 Hong Kong LTD Concert Pharmaceuticals, Inc. Transaction History

Point72 Hong Kong LTD

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$3.77 - $5.24 $10,819 - $15,038	-2,870 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$4.86 - $13.07 $9,229 - $24,819	1,899 Added 195.57%	2,870 $14,000
Q4 2020 Feb 16, 2021	SELL	$9.48 - $12.84 $4,218 - $5,713	-445 Reduced 31.43%	971 $12,000
Q3 2020 Nov 16, 2020	BUY	$8.67 - $10.82 $2,583 - $3,224	298 Added 26.65%	1,416 $14,000
Q2 2020 Aug 14, 2020	BUY	$7.8 - $11.52 $8,720 - $12,879	1,118 New	1,118 $11,000
Q3 2019 Nov 14, 2019	SELL	$5.88 - $12.35 $141 - $296	-24 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$9.44 - $13.12 $13,735 - $19,089	-1,455 Reduced 98.38%	24 $0
Q1 2019 May 15, 2019	BUY	$12.07 - $17.54 $17,851 - $25,941	1,479 New	1,479 $18,000
Q4 2017 Feb 14, 2018	SELL	$13.96 - $29.05 $1,591 - $3,311	-114 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$13.91 - $15.31 $1,585 - $1,745	114	114 $2,000

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.